BioSpace News Archive

Biotech Beach

Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference

Revelation Biosciences Inc. announced today that its Chief Executive Officer James Rolke will participate in a fireside chat at the 35th Annual Roth Conference scheduled for March 12-14, 2023 to be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.

March 6, 2023
·
2 min read
Drug Development

Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis

Harbour BioMed announces the positive topline results of its phase III clinical trial of batoclimab for the treatment of generalized myasthenia gravis, which is also the first positive pivotal trial outcome for batoclimab worldwide.

March 6, 2023
·
5 min read
Policy

Sooma Medical Receives FDA Breakthrough Device Designation for Its Innovative At-Home Depression Treatment Device

Sooma Medical, a medical device company based in Finland, has been granted Breakthrough Device designation by the U.S. Food and Drug Administration for its portable, patient-administered neuromodulation device to treat depression.

March 6, 2023
·
2 min read
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants

Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, are working together to commercialize innovative 3D-printed scaffolds for bone regeneration.

March 6, 2023
·
4 min read
Business

EyeBio Announces First Asset in Innovative Pipeline of Retinal Disease Treatments and Appoints Industry Leaders to Executive Team

Eyebiotech Limited announced several appointments to its executive team, featuring prominent industry leaders who are highly skilled in the development of multi-specific antibodies and ophthalmic drugs.

March 6, 2023
·
7 min read
Business

Orchard Therapeutics Provides Business Update and Reports 2022 Financial Results

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced business updates along with its financial results for the quarter and year ended December 31, 2022.

March 6, 2023
·
18 min read
Business

Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results

Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter and full year ended December 31, 2022.

March 6, 2023
·
18 min read
Drug Development

Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis

Armata Pharmaceuticals, Inc. today announced positive topline results from the completed Phase 1b/2a SWARM-P.a. trial evaluating AP-PA02, a novel, inhaled multi-phage therapeutic for the treatment of chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients.

March 6, 2023
·
6 min read
Business

Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the fourth quarter and year ended December 31, 2022 (fiscal 2022) and provided a corporate update.

March 6, 2023
·
10 min read
Business

Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones

Annexon, Inc. today outlined anticipated upcoming milestones across its portfolio of complement therapies and reported fourth quarter and full year 2022 financial results.

March 6, 2023
·
9 min read